asfotase alfa: Clinical Trials

2 trials of asfotase alfa, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow asfotase alfa: new trials by email Literature Review of asfotase alfa trials Research Report on asfotase alfa

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP)
asfotase alfa - Hypophosphatasia (HPP)
Phase 1 / Phase 2CompletedAlexion Pharmaceuticals, Inc.112008-09-012019-04-01
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Asfotase Alfa - Hypophosphatasia (HPP)
Phase 1CompletedAlexion Pharmaceuticals, Inc.62008-08-012019-03-29

Conditions studied

Bone Diseases (2)  ·  Hypophosphatasia (2)  ·  Osteomalacia (2)  ·  Rickets (2)

Sponsors

Alexion Pharmaceuticals, Inc. (2)

Countries

Canada (2)  ·  United States (2)  ·  United Arab Emirates (1)  ·  United Kingdom (1)

Results publications

PMID 22397652, PMID 26529632, PMID 32762706